Stockscreener 앱 받기
0.1856
3.23%
0.0058
시간 외 거래:
.19
0.0044
+2.37%
Liminatus Pharma Inc 주식(LIMN)의 최신 뉴스
Quarterly Recap: What is the cash position of Liminatus Pharma Inc2026 Trade Ideas & Free Reliable Trade Execution Plans - baoquankhu1.vn
Earnings Report: Is Liminatus Pharma Inc Equity Warrant stock undervalued right nowTrade Volume Report & Verified Stock Trade Ideas - baoquankhu1.vn
Resistance Check: Can INNOVATE Corp stock outperform in a bear marketEarnings Growth Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Quarterly Earnings: Can NRDS be recession proofGlobal Markets & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Update Recap: Will SOBR outperform during market rallies2026 Performance Recap & Reliable Breakout Forecasts - baoquankhu1.vn
Breakout Move: Can Liminatus Pharma Inc Equity Warrant reach resistance levels soonFed Meeting & Weekly Top Performers Watchlists - baoquankhu1.vn
LIMN Rebounds Close to Support Level, Yet Downward Trend Remains Firm - Bitget
Growth Value: Is Liminatus Pharma Inc forming a breakout pattern2026 Patterns & Entry Point Strategy Guides - baoquankhu1.vn
Retail Trends: Whats the fair value of Liminatus Pharma Inc Equity Warrant stock2026 Intraday Action & Weekly Sector Rotation Insights - baoquankhu1.vn
Liminatus Pharma 2025 Annual Report: Pre-Clinical Cancer Therapy Pipeline, Strategy, and Risk Overview - Minichart
Liminatus Pharma 2025 10-K — $0 Revenue, Net Loss $10.21M - TradingView — Track All Markets
Liminatus Pharma (NASDAQ: LIMN) faces cash strain, dilution and Nasdaq listing risks - Stock Titan
Liminatus Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Insider Trends: Is Liminatus Pharma Inc stock a smart retirement pick2026 PreEarnings & Weekly Return Optimization Plans - baoquankhu1.vn
FOMO Trade: Is Liminatus Pharma Inc a good ESG investment2026 Momentum & Capital Efficient Trading Techniques - baoquankhu1.vn
Institution Moves: Is Liminatus Pharma Inc stock a top performer YTD2026 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Liminatus Pharma, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Jobs Data: What are the future prospects of Liminatus Pharma Inc Equity WarrantTrade Analysis Report & AI Driven Price Predictions - baoquankhu1.vn
Fundamentals Check: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interest2026 Breakouts & Daily Profit Focused Stock Screening - baoquankhu1.vn
Moving Averages: What are Liminatus Pharma Incs recent SEC filings showingJobs Report & Verified Momentum Stock Alerts - baoquankhu1.vn
LIMN Stock Price, Quote & Chart | LIMINATUS PHARMA INC-CL A (NASDAQ:LIMN) - ChartMill
Weekly Earnings: Is Liminatus Pharma Inc Equity Warrant stock undervalued right nowMarket Activity Summary & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Aug Patterns: Can BPMC maintain its current growth rate2026 Fundamental Recap & Accurate Technical Buy Alerts - baoquankhu1.vn
Liminatus eyes clinic with CD47-blockade antibody IBA-101 - BioWorld MedTech
Liminatus Pharma to initiate Phase 1 clinical trial for IBA101 antibody - TipRanks
Liminatus Pharma’s IBA101 May Represent the CD47 Innovation Addressing Anemia and Thrombocytopenia in Advanced Immuno-Oncology - Bitget
Liminatus Pharma announces planned phase 1 clinical trial of IBA101, a next-generation CD47 blocking antibody - marketscreener.com
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody - The Manila Times
Liminatus Pharma Announces Planned Phase 1 Clinical Trial Of Iba101, A Next-Generation Cd47 Blocking Antibody - TradingView
New 'don't-eat-me' cancer antibody to be tested in Liminatus lung trial - Stock Titan
Aug Movers: Is Liminatus Pharma Inc stock a top performer YTD2026 Trends & Smart Money Movement Tracker - baoquankhu1.vn
Reviewing Athira Pharma (NASDAQ:LONA) and Liminatus Pharma (NASDAQ:LIMN) - Defense World
Insider Trends: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interestWeekly Trade Recap & Reliable Volume Spike Alerts - baoquankhu1.vn
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN
Aug Mood: Is Liminatus Pharma Inc a strong growth stock2026 Breakouts & Fast Moving Stock Trade Plans - baoquankhu1.vn
How Liminatus Pharma Inc. stock responds to policy changesQuarterly Earnings Report & Expert Curated Trade Setup Alerts - Naître et grandir
Winners Losers: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interestJuly 2025 Drop Watch & Weekly Momentum Picks - baoquankhu1.vn
Liminatus Pharma Lowers Quorum Requirement in Bylaw Amendment - TipRanks
Aug Update: Is Liminatus Pharma Inc stock a smart retirement pickJuly 2025 Retail & Reliable Entry Point Trade Alerts - baoquankhu1.vn
LIMN Earnings History & Surprises | EPS & Revenue Results | LIMINATUS PHARMA INC-CL A (NASDAQ:LIMN) - ChartMill
Liminatus Pharma (NASDAQ: LIMN) lowers quorum for shareholder votes - Stock Titan
LIMN Should I Buy - Intellectia AI
Basic earnings per share (basic EPS) of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Liminatus Pharma Inc. (NASDAQ:LIMN) Short Interest Up 4,357.6% in February - Defense World
LIMN PE Ratio & Valuation, Is LIMN Overvalued - Intellectia AI
Free float of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Critical Analysis: Liminatus Pharma (NASDAQ:LIMN) and Athira Pharma (NASDAQ:LONA) - Defense World
Net income of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Dividends – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation - The Ames Tribune
Aug EndMonth: What are Liminatus Pharma Incs recent SEC filings showingQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Earnings Risk: What are Liminatus Pharma Incs recent SEC filings showing2025 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Can Liminatus Pharma Inc. Equity Warrant stock deliver strong Q4 earnings2025 Historical Comparison & AI Forecast Swing Trade Picks - mfd.ru
Trend Recap: What is QSIAWs valuation compared to sectorProfit Target & High Conviction Investment Ideas - baoquankhu1.vn
Liminatus Pharma (NASDAQ: LIMN) insiders report 2.07M shares, 4.99% stake - Stock Titan
Liminatus Pharma Completes $4 Million Public Equity Offering - The Globe and Mail
Liminatus Pharma Prices $0.29 Equity Offering, Nets $3.46 Million Under Securities Purchase Pact - TradingView
Aug Highlights: Can Liminatus Pharma Inc Equity Warrant be recession proofJuly 2025 Short Interest & Verified Stock Trade Ideas - baoquankhu1.vn
Liminatus Pharma prices $4 million public offering at $0.29 per share - Investing.com India
Liminatus Pharma prices 13.8M shares at 29c in public offering - TipRanks
Gold Down 3%; Medtronic Earnings Top Views - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering - Bitget
2.69%
0.25%
자본화:
|
볼륨(24시간):